[HTML][HTML] Immune responses in mildly versus critically ill COVID-19 patients

H Nasrollahi, AG Talepoor, Z Saleh… - Frontiers in …, 2023 - frontiersin.org
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …

The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An update

SA Jasim, RS Mahdi, DO Bokov… - Journal of Medical …, 2022 - Wiley Online Library
The precise interaction between the immune system and severe acute respiratory syndrome
coronavirus 2 (SARS‑CoV‑2) is critical in deciphering the pathogenesis of coronavirus …

Dynamics of antibody response to CoronaVac vaccine

MHG Fonseca, TFG de Souza… - Journal of medical …, 2022 - Wiley Online Library
CoronaVac was the first vaccine approved in Brazil for use in healthcare workers (HCWs).
However, there is limited information about it, with little long‐term evidence on post …

Insights on the mechanisms of action of ozone in the medical therapy against COVID-19

S Chirumbolo, L Valdenassi, V Simonetti… - International …, 2021 - Elsevier
An increasing amount of reports in the literature is showing that medical ozone (O 3) is used,
with encouraging results, in treating COVID-19 patients, optimizing pain and symptoms …

COVID-19 Delta variants—Current status and implications as of August 2021

F Yu, LT Lau, M Fok, JYN Lau… - Precision Clinical …, 2021 - academic.oup.com
Abstract The SARS-CoV-2 Delta variant has evolved as the dominant strain of the current
pandemic. Studies have shown that this variant has increased infectivity/viral load, and …

[HTML][HTML] Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19

M Barnova, A Bobcakova, V Urdova… - Physiological …, 2021 - ncbi.nlm.nih.gov
Summary COVID-19 (Coronavirus Disease) is an infectious disease caused by the
coronavirus SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus 2), which …

[HTML][HTML] Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID

T Constantin, T Pék, Z Horváth, D Garan… - …, 2023 - Springer
The COVID-19 pandemic caused by the coronavirus 2 of the severe acute respiratory
syndrome (SARS-CoV-2) has significantly affected people around the world, leading to …

T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy

AT Reder, O Stuve, SK Tankou… - Multiple Sclerosis …, 2023 - journals.sagepub.com
Background: Multiple sclerosis (MS) is a neurological disorder marked by accumulating
immune-mediated damage to the central nervous system. The dysregulated immune system …

[HTML][HTML] High individual heterogeneity of neutralizing activities against the original strain and nine different variants of SARS-CoV-2

R Jaafar, C Boschi, S Aherfi, A Bancod, M Le Bideau… - Viruses, 2021 - mdpi.com
Background: Since the beginning of the COVID-19 pandemic, several SARS-CoV-2 variants
have sequentially emerged. In France, most cases were due to spike D641G-harbouring …

[PDF][PDF] PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2

S Mazumder, R Rastogi, A Undale, K Arora, NM Arora… - Heliyon, 2021 - cell.com
The rapid development of safe and effective vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS CoV-2) is a necessary response to coronavirus outbreak …